4sight Health December 1, 2021
David Burda

As I’ve said too many times to count, I’m not much for healthcare middlemen—distributors, benefits managers, wholesalers and group purchasing organizations—as I believe they add costs to the system rather than take costs out of the system as they profess in their value propositions. These middlemen have both hands out along the entire supply chain and grab as much cash as they can for themselves, their executives, their shareholders and their owners.

A great example of this, courtesy of a recent study in JAMA Health Forum, helps explain why prices for insulin to treat diabetes are so high. So high that a provision in the Build Back Better bill passed by the House and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Pricing / Spending, Provider, Supply Chain, Survey / Study, Technology, Trends
Mark Cuban's drug company teams up with platform to bring patients pricing info
California is Capping Health Care Cost Increases - Starting at 3.5% in 2025
Senator asks for investigation on use of algorithms in healthcare pricing
The Cost of Medical Care, Long-Term Care, and Prescription Drugs Top Older Americans’ Health-Related Concerns – With Social Security and Medicare Top of Mind
Opinion: The world is relying on the United States to get value-based drug pricing right

Share This Article